Joshua Zeidner: OPTI-AML Data Presented by Uma Borate Favor 28-Day Over 14-Day Aza/Ven Induction
Uma Borate/Joshua Zeidner

Joshua Zeidner: OPTI-AML Data Presented by Uma Borate Favor 28-Day Over 14-Day Aza/Ven Induction

Joshua Zeidner, Associate Professor of Medicine at the University of North Carolina at Chapel Hill, shared a post on X:

“Super proud of Uma Borate for delivering a fantastic presentation of the OPTI-AML data showing that Aza/Ven-14 is NOT equivalent to Aza/Ven-28 days at least for induction cycles 1-2. Highly impactful study from Blood Cancer United Research BEAT AML team

Joshua Zeidner

 

Other articles featuring Joshua Zeidner and Uma Borate on OncoDaily.